Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up
- PMID: 29407057
- DOI: 10.1016/j.ecl.2017.10.012
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up
Abstract
Type 1 diabetes mellitus, an autoimmune disorder characterized by beta-cell destruction and absolute insulin deficiency, is associated with significantly increased cardiovascular disease risk but the mechanisms underlying this enhanced risk are unclear. Results of the pivotal Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study have shown that compared to conventional therapy, intensive glycemic control results in decreased cardiovascular morbidity and mortality. Evidence from this study also revealed contributions of blood pressure, renal disease, body weight, and lipids to cardiovascular disease in type 1 diabetes mellitus. Extrapolating from existing evidence, this article addresses clinical strategies to mitigate cardiovascular risks.
Keywords: Cardiovascular; DCCT; Diabetes; EDIC; Mortality; Risk.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.Diabetes Care. 2017 Dec;40(12):1756-1762. doi: 10.2337/dc16-2523. Diabetes Care. 2017. PMID: 29138273 Free PMC article. Clinical Trial.
-
Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).Circulation. 2009 Jun 9;119(22):2886-93. doi: 10.1161/CIRCULATIONAHA.108.837369. Epub 2009 May 26. Circulation. 2009. PMID: 19470886 Free PMC article. Clinical Trial.
-
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.Circulation. 2005 May 17;111(19):2446-53. doi: 10.1161/01.CIR.0000165064.31505.3B. Epub 2005 May 2. Circulation. 2005. PMID: 15867184 Clinical Trial.
-
Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes.Curr Cardiol Rep. 2016 Mar;18(3):29. doi: 10.1007/s11886-016-0700-6. Curr Cardiol Rep. 2016. PMID: 26886228 Review.
-
Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now.Int Rev Neurobiol. 2016;127:9-25. doi: 10.1016/bs.irn.2016.02.020. Epub 2016 Apr 8. Int Rev Neurobiol. 2016. PMID: 27133142 Review.
Cited by
-
Urinary glucose excretion after dapagliflozin treatment: An exposure-response modelling comparison between Japanese and non-Japanese patients diagnosed with type 1 diabetes mellitus.Diabetes Obes Metab. 2019 Apr;21(4):829-836. doi: 10.1111/dom.13586. Epub 2018 Dec 16. Diabetes Obes Metab. 2019. PMID: 30456904 Free PMC article.
-
Targeted delivery of harmine to xenografted human pancreatic islets promotes robust cell proliferation.Sci Rep. 2022 Nov 9;12(1):19127. doi: 10.1038/s41598-022-19453-5. Sci Rep. 2022. PMID: 36351917 Free PMC article.
-
Management of diabetes complications in youth.Ther Adv Endocrinol Metab. 2019 Jul 25;10:2042018819863226. doi: 10.1177/2042018819863226. eCollection 2019. Ther Adv Endocrinol Metab. 2019. PMID: 31384418 Free PMC article. Review.
-
Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?Nutrients. 2019 May 7;11(5):1022. doi: 10.3390/nu11051022. Nutrients. 2019. PMID: 31067747 Free PMC article. Review.
-
Epidemiology and risk factors of hypoglycemia in subjects with type 1 diabetes in Brazil: a cross-sectional, multicenter study.Arch Endocrinol Metab. 2022 Nov 17;66(6):784-791. doi: 10.20945/2359-3997000000523. Epub 2022 Oct 3. Arch Endocrinol Metab. 2022. PMID: 36191264 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
